laitimes

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Cancer Biology and Medicine

Cancer Biology & Medicine

Co-sponsored by the Chinese Anti-Cancer Association and Tianjin Medical University Cancer Hospital, it focuses on tumor translational research and is committed to building a bridge between basic scientific research and clinical diagnosis and treatment. The journal has been indexed by major domestic and foreign databases such as SCIE (IF=5.6, 5-year IF 5.9), MEDLINE, and PubMed/PubMed Central. As an OA journal, readers can view the full text through this link http://www.ncbi.nlm.nih.gov/pmc/journals/2000/

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Editorial

Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research

Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao

Epigenetic regulators as the foundation for molecular classification of colorectal cancer

Zhenyu Liu, Xin Zhou and Fuchou Tang

Reviews

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Modeling human gastric cancers in immunocompetent mice

Weihong Zhang, Shilong Wang, Hui Zhang, Yan Meng, Shi Jiao, Liwei An and Zhaocai Zhou

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Research progress in tumor angiogenesis and drug resistance in breast cancer

Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng and Hongchao Tang

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei

Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li and Yan Li

Original Article

ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis

Shirong Tan, Xiangyu Sun, Haoran Dong, Mozhi Wang, Litong Yao, Mengshen Wang, Ling Xu and Yingying Xu

Recommendation of the Excellence Action Plan for Chinese Scientific and Technological Journals: Cancer Biology and Medicine, Issue 7, 2024

Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer

Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba

Read on